Trametinib and Hydroxychloroquine in Treating Patients with Pancreatic Cancer (THREAD)
University of Utah / Novartis PharmaceuticalsClinicalTrials.gov Identifier: NCT03825289
Trametinib PubChem CID: 11707110
See complete details, including study location(s), eligibility criteria, contact information, and study results (when available) at ClinicalTrials.gov.
Send email to avery@williamaveryhudson.com for information about submitting qualified clinical trials for sponsored posts on this blog.
The information on my blog is not intended as a substitute for medical professional help or advice but is to be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.